APA (7th ed.) Citation

Jin, Y., Liu, Q., Sun, B., Li, X., Wu, J., Lin, Z., . . . Jia, H. (2024). Pralatrexate represses the resistance of HCC cells to molecular targeted agents via the miRNA-34a/Notch pathway. Discover Oncology, 15(1), 1. https://doi.org/10.1007/s12672-024-01572-2

Chicago Style (17th ed.) Citation

Jin, Yang, Qiming Liu, Baisheng Sun, Xiaokang Li, Jiahao Wu, Zhiyuan Lin, Yan Ma, and Haijiang Jia. "Pralatrexate Represses the Resistance of HCC Cells to Molecular Targeted Agents via the MiRNA-34a/Notch Pathway." Discover Oncology 15, no. 1 (2024): 1. https://doi.org/10.1007/s12672-024-01572-2.

MLA (9th ed.) Citation

Jin, Yang, et al. "Pralatrexate Represses the Resistance of HCC Cells to Molecular Targeted Agents via the MiRNA-34a/Notch Pathway." Discover Oncology, vol. 15, no. 1, 2024, p. 1, https://doi.org/10.1007/s12672-024-01572-2.